⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22725520 | 0.74 | RXRA (0.30) | — | |
| SCHEMBL18494814 | 0.73 | RXRA (0.32) | — | |
| SCHEMBL21516067 | 0.72 | RXRA (0.31) | — | |
| SCHEMBL12120619 | 0.70 | RXRA (0.33) | — | |
| SCHEMBL22725514 | 0.70 | — | — | |
| SCHEMBL18950388 | 0.70 | APLNR (0.35) | — | |
| SCHEMBL8860817 | 0.69 | TSHR (0.32) | — | |
| SCHEMBL31069875 | 0.68 | — | — | |
| SCHEMBL13444709 | 0.68 | — | — | |
| SCHEMBL10267302 | 0.65 | RXRA (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11091462-B2 | (Hetero)arylamide compound for inhibiting protein kinase activity | SHENZHEN TARGETRX, INC. (CN) | 2021-08-17 | — | — | US | disclosed |
| US-20200377473-A9 | (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY | SHENZHEN TARGETRX, INC. (CN) | 2020-12-03 | — | — | US | disclosed |